Lalloo U - Search Results

1

HIV prevention counseling intervention delivered during routine clinical care reduces HIV risk behavior in HIV-infected South Africans receiving antiretroviral therapy: the Izindlela Zokuphila/Options for Health randomized trial.

Fisher JD, Cornman DH, Shuper PA, Christie S, Pillay S, Macdonald S, Ngcobo N, Amico KR, Lalloo U, Friedland G, Fisher WA; SA Options Team. Fisher JD, et al. Among authors: lalloo u. J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):499-507. doi: 10.1097/QAI.0000000000000348. J Acquir Immune Defic Syndr. 2014. PMID: 25230288 Free PMC article. Clinical Trial.

2

A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting.

Jack C, Lalloo U, Karim QA, Karim SA, El-Sadr W, Cassol S, Friedland G. Jack C, et al. Among authors: lalloo u. J Acquir Immune Defic Syndr. 2004 Aug 1;36(4):929-34. doi: 10.1097/00126334-200408010-00006. J Acquir Immune Defic Syndr. 2004. PMID: 15220699 Clinical Trial.

3

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.

Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. Gandhi NR, et al. Among authors: lalloo u. Lancet. 2006 Nov 4;368(9547):1575-80. doi: 10.1016/S0140-6736(06)69573-1. Lancet. 2006. PMID: 17084757

4

Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba study.

Gandhi NR, Moll AP, Lalloo U, Pawinski R, Zeller K, Moodley P, Meyer E, Friedland G; Tugela Ferry Care and Research (TFCaRes) Collaboration. Gandhi NR, et al. Among authors: lalloo u. J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):37-43. doi: 10.1097/QAI.0b013e31818ce6c4. J Acquir Immune Defic Syndr. 2009. PMID: 19295333 Clinical Trial.

5

Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV.

Friedland G, Khoo S, Jack C, Lalloo U. Friedland G, et al. Among authors: lalloo u. J Antimicrob Chemother. 2006 Dec;58(6):1299-302. doi: 10.1093/jac/dkl399. Epub 2006 Oct 10. J Antimicrob Chemother. 2006. PMID: 17032686

6

Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.

Friedland G, Abdool Karim S, Abdool Karim Q, Lalloo U, Jack C, Gandhi N, El Sadr W. Friedland G, et al. Among authors: lalloo u. Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S421-8. doi: 10.1086/421407. Clin Infect Dis. 2004. PMID: 15156433

7

Blood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional study.

Heysell SK, Thomas TA, Gandhi NR, Moll AP, Eksteen FJ, Coovadia Y, Roux L, Babaria P, Lalloo U, Friedland G, Shah S. Heysell SK, et al. Among authors: lalloo u. BMC Infect Dis. 2010 Dec 6;10:344. doi: 10.1186/1471-2334-10-344. BMC Infect Dis. 2010. PMID: 21134279 Free PMC article.

8

Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase.

Brehm JH, Lalama CM, Hughes MD, Haubrich R, Riddler SA, Sluis-Cremer N, Mellors JW; AIDS Clinical Trials Group Study A5142 Protocol Team. Brehm JH, et al. J Acquir Immune Defic Syndr. 2011 Apr;56(4):344-8. doi: 10.1097/QAI.0b013e31820cf029. J Acquir Immune Defic Syndr. 2011. PMID: 21350368 Free PMC article.

9

Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care.

Abdool-Karim SS, Abdool-Karim Q, Friedland G, Lalloo U, El-Sadr WM; START project. Abdool-Karim SS, et al. Among authors: lalloo u. AIDS. 2004 Apr 30;18(7):975-9. doi: 10.1097/00002030-200404300-00004. AIDS. 2004. PMID: 15096799 Review. No abstract available.

10

Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8.

Cassol E, Page T, Mosam A, Friedland G, Jack C, Lalloo U, Kopetka J, Patterson B, Esterhuizen T, Coovadia HM. Cassol E, et al. Among authors: lalloo u. J Infect Dis. 2005 Feb 1;191(3):324-32. doi: 10.1086/427337. Epub 2004 Dec 22. J Infect Dis. 2005. PMID: 15633090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page